---
title: "Damora Therapeutics, Inc. (DMRA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DMRA.US.md"
symbol: "DMRA.US"
name: "Damora Therapeutics, Inc."
industry: "Biotechnology"
datetime: "2026-03-11T16:13:54.799Z"
locales:
  - [en](https://longbridge.com/en/quote/DMRA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DMRA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DMRA.US.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/DMRA.US.md) | [繁體中文](https://longbridge.com/zh-HK/quote/DMRA.US.md)


# Damora Therapeutics, Inc. (DMRA.US)

## Company Overview

Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [galecto.com](https://galecto.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -96.99 | - | - | - | - |
| PB | 230.53 | - | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-03-11T04:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.33 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/DMRA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/DMRA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/DMRA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/DMRA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**